Viewing Study NCT01351935


Ignite Creation Date: 2025-12-24 @ 10:33 PM
Ignite Modification Date: 2025-12-31 @ 12:26 AM
Study NCT ID: NCT01351935
Status: COMPLETED
Last Update Posted: 2019-11-08
First Post: 2011-05-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Sponsor: Celgene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module